---
schema_version: "secwatch.filing_event.v1"
accession: "0001388658-22-000126"
form_type: "8-K"
ticker: "IRTC"
cik: "0001388658"
company_name: "iRhythm Holdings, Inc."
filed_at: "2022-08-05T23:59:59+00:00"
generated_at: "2026-06-24T03:15:11.963995+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# iRhythm Q2 revenue $102.1M (+26% YoY), raises FY22 guidance to $415-420M, loss widens

## Summary
- Revenue $102.1M (+25.6% YoY); gross margin 68.8% (up 0.8pp).
- Net loss $23.9M ($0.80 loss per share) vs $17.4M loss in Q2 2021.
- FY22 revenue guidance raised to $415-420M (29-30% growth); adj. EBITDA loss guidance $(12.5)-$(17.5)M.
- Cash $204.5M; record new account openings (+22% QoQ) and sequential revenue volume growth of 10%.
- FDA 510(k) cleared Zio Watch (Verily partnership); CMS proposed reimbursement for Zio XT CPT codes.

## SEC filing metadata
- accession: 0001388658-22-000126
- form_type: 8-K
- ticker: IRTC
- cik: 0001388658
- company_name: iRhythm Holdings, Inc.
- filed_at: 2022-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388658/000138865822000126/0001388658-22-000126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388658/000138865822000126/irtc-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001388658-22-000126
- JSON: https://secwatch.observer/filing/0001388658-22-000126.json
- Plain text: https://secwatch.observer/filing/0001388658-22-000126.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.